Bernd Eichenmueller

Bernd EichenmüllerGlobal Head Bioprocess Technology Shift, Boehringer Ingelheim Animal Health

Bernd Eichenmueller oversees the implementation of state-of-the-art and innovative manufacturing technologies in the veterinary vaccine manufacturing facilities of the global BIAH network. He joined Boehringer Ingelheim 18 years ago and has held several management positions with increasing responsibility including Process Development, Vaccine Production and US Operations before his current role.

Eichenmueller holds a Ph.D. in Bioprocess Engineering from the Technical University Berlin, Germany, and completed a three-year post-doctoral assignment at the University of Kansas in the Department of Molecular Biosciences.